Skip Navigation



Japanese Journal of Clinical Oncology Advance Access published online on September 5, 2008
Japanese Journal of Clinical Oncology, doi:10.1093/jjco/hyn090
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
38/10/670    most recent
hyn090v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hou, C.
Right arrow Articles by Jin, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hou, C.
Right arrow Articles by Jin, X.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2008). Published by Oxford University Press. All rights reserved

Autologous Bone Marrow Stromal Cells Transplantation for the Treatment of Secondary Arm Lymphedema: A Prospective Controlled Study in Patients with Breast Cancer Related Lymphedema

Chuanqiang Hou, Xuejun Wu and Xing Jin

Department of Vascular Surgery, Shandong Provincial Hospital, Shandong University, Shandong, China

For reprints and all correspondence: Xing Jin, Department of Vascular Surgery, Shandong Provincial Hospital, 324 Jingwu Road, Jinan 250021, Shandong Province, China. E-mail: jinxingjn{at}yahoo.cn

Received July 9, 2008; accepted August 7, 2008

Objective: To determine the short- and long-term effect of bone marrow stromal cells (BMSCs) transplantation as a treatment for breast cancer-related lymphedema. To contrast it with complex decongestive physiotherapy (CDT).

Methods: Fifteen women with lymphedema, who had undergone breast cancer surgery and/no radiotherapy 5 years before, served as the experimental group and received BMSC transplantation; 35 patients were measured as the control group treated with CDT. They were kept on follow-up for 1 year.

Results: Two patients in the CDT Group failed to keep follow-up. Before treatment, patients had average volume of edema in the affected arm of 1166.2 ml in BMSC Group and 1091.0 ml in the CDT Group. With therapy, there was an average decrease in lymphedema volume of 730.7, 887.9 and 958.6 ml in the BMSC Group and 714.8, 657.9 and 571.3 ml in the CDT Group after 1, 3 and 12 months, respectively. Before treatment, the percentage of lymphedema was 28.6% in the BMSC Group and 26.8% in the CDT Group. After treatment, there was a decrease of 64.6, 78.5 and 81.0% in the BMSC Group and 67.2, 60.4 and 54.5% in the CDT Group after 1, 3 and 12 months, respectively. When asked to quantify subjectively their pain on a numeric scale from 0 to 5, the average score of these patients was 3.4 in the BMSC group and 4.0 in the CDT Group. The average score was reduced to 1.6, 0.8 and 0.6 in the BMSC Group and to 1.2, 1.7 and 1.6 in CDT Group after 1, 3 and 12 months, respectively.

Conclusions: Autologous BMSCs transplantation for the treatment of breast cancer related lymphedema is effective and feasible.

Key Words: bone marrow stromal cells • lymphedema • transplantation • breast cancer • complex decongestive physiotherapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.